TSHR antagonist S37a is a highly specific thyrotropin receptor (TSHR) antagonist, with highly potential for the treatment of Graves' orbitopathy. References: [1]. Marcinkowski P, et al. A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy. Thyroid. 2019 Jan;29(1):111-123.

纯度：≥98%

CAS：2143452-20-2